Pathos is a clinical-stage biotechnology company focused on re-engineering drug development, leveraging the power of advanced AI technologies to bring precision medicines to market through partnerships with biopharmaceutical companies.

PathOS Platform™ is fueled by petabytes of real-world oncology data and patient-derived functional genomic data to identify and validate compelling biology that would have otherwise gone undetected using traditional methods. We are 100% dedicated to partnering with drug companies to develop their shelved programs by applying AI to optimize patient selection strategies.

We license or co-develop clinical-stage therapeutics to ensure highly efficacious drugs are developed for the patients most likely to benefit and with significant unmet needs. Our patient selection strategies are optimized for the fastest path to approval to improve patient outcomes as quickly as possible.

Pathos was born out of the idea that AI can transform each step of the drug development process — patient selection, biomarker development, trial design, and clinical trial operations — to bring precision medicines to market at an unimaginable pace. Our aim is ultimately to accelerate the translation of real-world data into breakthrough therapies for patients that need them most.

Pathos was borne from the belief that cancer is a collection of hundreds of rare diseases and can be best described by pathways accounting for the pathophysiology of patients. We know the current all-comers approach won’t work. If we truly want to develop drugs for the hundreds of cancers, we will have to completely re-engineer the entire drug development process tuned to support these smaller populations.

At Pathos, we are trailblazers in the fight against cancer, relentless in our pursuit of revolutionary treatments for patients. We are a diverse team united by a shared passion for innovation and a commitment to moving with purpose, improving daily, exploring the unknown, and delivering precision medicine as a standard of care for all, striving to leave no patient behind. Our unique perspectives and backgrounds fuel our progress as we strive to push the boundaries of what is possible. We are dedicated to attracting the brightest minds and the boldest hearts to join us on this mission, building a culture of accountability and excellence that propels us toward a brighter future for cancer patients everywhere.